Skip to main content
HCONRES 113 105th Congress House

Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.

Introduced: July 9, 1997 See on congress.gov
Health Administrative procedureAir pollution controlAsthmaChlorofluorocarbons
More subjectsShow fewer subjects
CommerceDepartment of Health and Human ServicesDrug industryDrugsEnvironmental ProtectionGovernment Operations and PoliticsInternational AffairsInternational environmental cooperationLawMedical suppliesOzone layer depletionTreaties
Sign in to write a letter Sign in to watch
This resolution expired with the 105th Congress
It was not agreed to before the 105th Congress (1997–1998) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Jul 14, 1997
Referred to the Subcommittee on Health and Environment.
Jul 9, 1997
Referred to the House Committee on Commerce.
Jul 9, 1997
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 14, 1997

Referred to the Subcommittee on Health and Environment.

 Plain-English summary Congressional Research Service

Expresses the sense of the Congress that: (1) a specified proposed Food and Drug Administration (FDA) regulation to designate the use of chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs) as nonessential so as to make MDIs using CFCs adulterated devices puts at risk the health of millions of asthma patients and does not contribute measurably to protection of the environment; and (2) the FDA should withdraw its proposal and focus its efforts on implementing existing Montreal Protocol decisions that will facilitate a transition to CFC-free MDIs by 2005.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Smith, Christopher H.
New Jersey · Jul 9, 1997
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 113: Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.. 105th Congress. Open America. https://openamerica.io/bill/105-HCONRES-113/
MLA
"H. Con. Res. 113: Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HCONRES-113/.
Bluebook (legal)
H. Con. Res. 113, 105th Cong. (2026), https://openamerica.io/bill/105-HCONRES-113/.
Markdown link
[H. Con. Res. 113: Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.](https://openamerica.io/bill/105-HCONRES-113/)
Report a problem